Exercise may be as effective as psychological therapies and potentially even antidepressants in treating depression, a new study suggests. Researchers at the University of Lancashire, reviewing 73 ...

The MHRA has authorised GSK’s Nucala (mepolizumab) in the UK as an add‑on maintenance treatment for adults with uncontrolled COPD of an eosinophilic phenotype who are already receiving triple therapy ...

· The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

(Sharecast News) - Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD). Following ...

In adults with Fontan circulation, a higher pulmonary vascular resistance index (PVRI) during exercise and failure to reduce the PVRI were associated with a greater risk for death or heart ...

The Dutch air-defence frigate HNLMS Evertsen (top), pictured during its CSG21 deployment, recently completed UK ‘Sharpshooter' counter-unmanned systems training. (US Navy photo, courtesy of Royal Navy ...

TAIPEI (Taiwan News) — The UK condemned China’s military exercise around Taiwan in a statement issued on Tuesday. China’s exercise included patrols, blockade maneuvers, establishing deterrence, and ...

The latest announcement is out from Greencoat UK Wind ( (GB:UKW)). Greencoat UK Wind PLC has executed a share buyback program, purchasing 50,000 ordinary shares at an average price of 96.74 pence per ...

Patients undergoing treatment for lymphoma often experience adverse side effects that can be so severe that they stop or slow treatment. But a new study shows that a virtual program focusing on diet ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? My name is Cori Ritchey, and I am an exercise physiology nerd turned fitness ...

Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial This ...